Genfit's NASH key phase 3 data delayed

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Feb 21, 2020 at 10:42 AM.

  1. #1 cafead, Feb 21, 2020 at 10:42 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,979
    Likes Received:
    3
    via Genfit’s shares were in the red Friday morning after the French biotech announced it was delaying a data readout for its potential blockbuster fatty liver hopeful elafibranor.

    article source
     
    Quote

Reply to Thread